LONDON/PARIS, Oct 21 (Reuters) - Swiss skincare firm Galderma (GALD.S), opens new tab, Brazilian cosmetics group Natura ...

Pfizer Inc. hit a new 52-week high, surpassing its previous peak of $29.88, which the company reached on October 15th. Supported by world-class markets data from Dow Jones and FactSet, and partnering ...

Wall Street rises as healthcare stocks surge and oil prices soften. Discover the latest market trends and sector performance.

We've compiled a comprehensive list of every uniform and logo change, as well as every new court design and jersey patch ...

Swiss pharma giant Roche is putting future decisions on investment in Germany on hold, the company said on Monday, amid ...

Scott Gottlieb, the Food and Drug Administration commissioner turned Pfizer director and prominent critic of Robert Kennedy ...

Tesla has unveiled its new Roadster sports car, which can thrust itself in the air, among other engineering bells and ...

Ahead of the event, analysts expect Pfizer to report a profit of $0.72 per share on a diluted basis, down 17.2% from $0.87 per share in the year-ago quarter. The company has consistently surpassed ...

Pfizer Inc PFE shares are climbing Thursday to a new 52-week high as drugmakers rally broadly. The move comes a week after ...

Complaints allege early onset dementia and neurocognitive decline due to the medications, alleging Pfizer and its ...

Qurient could begin third-party licensing of its CDK7 inhibitor platform this year through Lonza, Shinhan Securities said.